Biomarker-Integrated Digital Guidance for Early Alzheimer's Detection (BRIDGE-AD): A Nationwide Multicenter Study
Recruiting · NCT07284264 · Observational (researchers observe without assigning treatment) · Lead sponsor: Xuanwu Hospital, Beijing
View the official record on ClinicalTrials.gov →What this trial is about
The investigators propose a stepwise screening approach. The first step involves rapid digital pre-screening of cognitive function through three components: the SCD-9 questionnaire to capture subjective cognitive complaints, a digital cognitive assessment to evaluate objective performance, and a predictive model to estimate future dementia risk in cognitively normal individuals. The second step confirms the presence of AD pathology using blood-based biomarkers, with a head-to-head comparison of multiple novel candidates to identify those with the greatest diagnostic utility.
Who can take part
Inclusion criteria
- adults aged 50 and above;
- living in community for at least one year and having established medical records;
- denying a history of cognitive disorders (mild cognitive impairment, dementia, Alzheimer's disease, etc.) and the use of anti-dementia drugs (cholinesterase inhibitors or memantine, etc.);
- agreeing to participate in the study;
- individual or their relatives can communicate normally in Chinese.
- high-risk groups for dementia(including:1. Complaints of cognitive decline and/or statements by the informant;2. History of AD in first-degree relatives;3. Known ApoE e4 carrier.)
Exclusion criteria
- Self-reporting or confirmation through inquiry indicates the presence of severe mental disorders, such as bipolar disorder or schizophrenia, etc.
- Having a disease that makes it impossible to complete the cognitive assessment.
Where it is running
6 locations listed.
- Xuanwu Hospital, Capital Medical University - Beijing, China
- Hainan Medical University - Hainan, China
- General Hospital of Ningxia Medical University - Ningxiang, China
- The First Hospital of China Medical Unversity - Shenyang, China
- Shenzhen Center For Chronic Disease Control - Shenzhen, China
- Yichun People'S Hospital - Yichun, China